Parabilis Medicines Inc. Common Stock (PBLS)
Stock · NASDAQ · Health Care
$39.11as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Industry
Biotechnology: Pharmaceutical Preparations
About PBLS
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targete…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 145
- Website
- parabilismed.com
Fundamentals
- 1-day range
- $39.17$41.35
- Market cap
- $4.23B
- P/E (trailing)
- —
- P/E (forward)
- -18.90
- EPS (trailing)
- $-1.88
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 708.7K
52-week range
$24.51$41.35
Next earnings: November 12, 2026 · EPS estimate $-0.38
Forecasts
4 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$45
+15.1%
Median
$41
+4.8%
Low
$40
+2.3%
Parabilis Medicines Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PBLSParabilis Medicines Inc. Common Stock$39.11▼ 0.46%Market cap $4.23BP/E —$24.51$41.35
- MANEVeradermics Incorporated Common Stock$97.53▼ 4.20%Market cap $4.54BP/E —$32$131.24
- VKTXViking Therapeutics Inc. Common Stock$32.15▼ 5.05%Market cap $3.88BP/E —$22.96$43.15
- GPCRStructure Therapeutics Inc. American Depositary Shares$47.38▼ 3.74%Market cap $3.74BP/E —$18.26$94.9
- ELVNEnliven Therapeutics Inc. Common Stock$57.82▼ 4.43%Market cap $3.67BP/E —$14.79$62.32
- INDVIndivior Pharmaceuticals Inc. Common Stock$34.87▼ 1.22%Market cap $4.82BP/E 12.77$22.22$42.81
- TLXTelix Pharmaceuticals Limited American Depositary Shares$11.28▼ 0.84%Market cap $3.60BP/E —$6.28$12.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PBLS Parabilis Medicines Inc. Common Stock | $4.23B | — | $39.11 | ▼ 0.46% | $24.51$41.35 |
| MANE Veradermics Incorporated Common Stock | $4.54B | — | $97.53 | ▼ 4.20% | $32$131.24 |
| VKTX Viking Therapeutics Inc. Common Stock | $3.88B | — | $32.15 | ▼ 5.05% | $22.96$43.15 |
| GPCR Structure Therapeutics Inc. American Depositary Shares | $3.74B | — | $47.38 | ▼ 3.74% | $18.26$94.9 |
| ELVN Enliven Therapeutics Inc. Common Stock | $3.67B | — | $57.82 | ▼ 4.43% | $14.79$62.32 |
| INDV Indivior Pharmaceuticals Inc. Common Stock | $4.82B | 12.77 | $34.87 | ▼ 1.22% | $22.22$42.81 |
| TLX Telix Pharmaceuticals Limited American Depositary Shares | $3.60B | — | $11.28 | ▼ 0.84% | $6.28$12.5 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.